Robbins Geller Announces Mid-Year Achievements for 2015

August 6, 2015

Robbins Geller is proud to report on its achievements for the first half of 2015, recovering more than $2 billion for institutional investors around the globe.

Just last week, the Firm obtained court approval of a $400 million recovery for shareholders in a class action against Pfizer Inc. where the settlement was reached just days before trial was to commence.  The result, against the world’s largest pharmaceutical manufacturer, is a testament to both the tenacity of Robbins Geller’s litigation team and to the vigorous prosecution of the case for more than five years.  Knowing what it faced at trial, Pfizer opted instead to settle the case – an excellent result in a case no other firm filed.

In other recent news, Robbins Geller recovered $388 million for a class of purchasers of nine 2007 residential mortgage-backed securities (MBS) trusts issued by J.P. Morgan – bringing to a successful conclusion one of the last remaining MBS purchaser class actions arising out of the global financial crisis. The settlement represents, on a percentage basis, the largest recovery ever achieved in an MBS purchaser class action.

And, earlier this year, Robbins Geller also obtained settlements in several other matters where trials were fast approaching.  For example, the Firm settled a shareholder class action against Psychiatric Solutions for $65 million less than two weeks before trial after defeating multiple unsuccessful attempts by defendants to have the district court’s decisions overturned on appeal.  Robbins Geller served as co-lead counsel in a shareholder antitrust class action against some of the world’s largest private equity firms which ultimately yielded over $590 million for investors in a series of settlements, with the lone remaining defendant settling only as trial loomed.  That settlement represents the largest antitrust class action settlement ever in which no civil or criminal government antitrust action was taken.

As the voice of injured investors, the Firm continues to promote corporate responsibility and protect the integrity of the financial markets.

Main Menu